Laryngomalacia is the most common congenital laryngeal anomaly in children and is frequently associated with aspiration. This randomized controlled study aims to assess the role of proton pump inhibitor (PPI) therapy in reducing the incidence of aspiration in pediatric patients with laryngomalacia. Eligible participants will be randomly assigned to either a PPI treatment group or a control group. Clinical and swallowing assessments will be performed to compare aspiration incidence and swallowing outcomes between the two groups
Inclusion Criteria:
Exclusion Criteria:
This is an open-label study. Participants, caregivers, investigators, and outcome assessors are aware of the assigned intervention
Participants receive PPI therapy in addition to vitamin D supplementation and feeding instructions.
Participants receive vitamin D supplementation and feeding instructions only.
Minya, Minya Governorate, Egypt
alshima.dakhly@mu.edu.eg01033487196
In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion
LGG for Prevention of Infectious Complications During PPI Treatment in Children
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux